The open-label design may have also contributed ... Therefore, the primary comparison in this trial was between 25 mg of hydrochlorothiazide and 12.5 mg of chlorthalidone. These results should ...

A potentially life-threatening label mix-up has led to a nationwide ... Healthcare Inc. is voluntarily recalling one lot of 12.5 mg hydrochlorothiazide tablets after a 100-count bottle of the ...

No, hydrochlorothiazide doesn’t treat COVID-19. The drug isn’t approved for this use, and isn’t prescribed off-label for this condition, either. (With off-label use, a drug that’s approved ...

Antihypertensive efficacy and safety of losartan/hydrochlorothiazide (HCTZ ... mg/HCTZ 12.5 mg and to losartan 100 mg/HCTZ 25 mg, respectively. Data analysis included 430 patients with ...

For the open-label study, patients were randomized to either continue treatment with hydrochlorothiazide or switch to chlorthalidone (12.5 or 25 mg). With an average follow-up of 4.2 years ...

Unichem Pharmaceuticals issued a voluntary nationwide recall of Hydrochlorothiazide 25mg tablets after the discovery of a Clopidogrel tablet in a bottle. Unichem Pharmaceuticals issued a voluntary ...

90 count BEF8D022 4/30/2020 13668-118-30 Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 30 count BEF6D038 4/30/2020 13668-118-90 Losartan Potassium/ Hydrochlorothiazide Tablets ...

The addition of hydrochlorothiazide (HCTZ) 12.5 and 25 mg to OM 20 mg has been shown ... control following 8 weeks of treatment with open-label OM 40 mg. The study also assessed the efficacy ...

Conclusion: These results show that there is little or no potential for a clinically relevant pharmacokinetic interaction between olmesartan medoxomil 20mg and hydrochlorothiazide 25mg ...

In combination with hydrochlorothiazide, it is used in the treatment of hypertension. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior ...